The DOI matches its Crossref record; 280 of the 280 references it cites were found in a registry or an index.
Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases
Open accessAbstract
Glycogen synthase kinase‐3 (GSK3) is a highly evolutionarily conserved serine/threonine protein kinase first identified as an enzyme that regulates glycogen synthase (GS) in response to insulin stimulation, which involves GSK3 regulation of glucose metabolism and energy homeostasis. Both isoforms of GSK3, GSK3α, and GSK3β, have been implicated in many biological and pathophysiological processes. The various functions of GSK3 are indicated by its widespread distribution in multiple cell types and tissues. The studies of GSK3 activity using animal models and the observed effects of GSK3‐specific inhibitors provide more insights into the roles of GSK3 in regulating energy metabolism and homeostasis. The cross‐talk between GSK3 and some important energy regulators and sensors and the regulation of GSK3 in mitochondrial activity and component function further highlight the molecular mechanisms in which GSK3 is involved to regulate the metabolic activity, beyond its classical regulatory effect on GS. In this review, we summarize the specific roles of GSK3 in energy metabolism regulation in tissues that are tightly associated with energy metabolism and the functions of GSK3 in the development of metabolic disorders. We also address the impacts of GSK3 on the regulation of mitochondrial function, activity and associated metabolic regulation. The application of GSK3 inhibitors in clinical tests will be highlighted too. Interactions between GSK3 and important energy regulators and GSK3‐mediated responses to different stresses that are related to metabolism are described to provide a brief overview of previously less‐appreciated biological functions of GSK3 in energy metabolism and associated diseases through its regulation of GS and other functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mora, A., Sakamoto, K., McManus, E. J., & Alessi, D. R. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.05.040 · Cited by 90
RetractedCentral nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014) · Physiological Reviews · doi:10.1152/physrev.00026.2013 · Cited by 5,383
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
Garcia, D., & Shaw, R. J. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.032 · Cited by 1,978
Inhibition of Adipogenesis by Wnt Signaling
Ross, S. E., Hemati, N., Longo, K. A., Bennett, C. N., Lucas, P. C., Erickson, R. L., & MacDougald, O. A. (2000) · Science · doi:10.1126/science.289.5481.950 · Cited by 1,874
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Cantó, C., & Auwerx, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328328d0a4 · Cited by 1,624
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
Abel, E. D., Peroni, O., Kim, J. K., Kim, Y.-B., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., & Kahn, B. B. (2001) · Nature · doi:10.1038/35055575 · Cited by 1,253
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195
AMPK: Sensing Glucose as well as Cellular Energy Status
Lin, S.-C., & Hardie, D. G. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.009 · Cited by 1,191
The axonal transport of mitochondria
Saxton, W. M., & Hollenbeck, P. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.053850 · Cited by 1,185
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Schroder, K., Zhou, R., & Tschopp, J. (2010) · Science · doi:10.1126/science.1184003 · Cited by 1,134
Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J., & Dedhar, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11211 · Cited by 1,092
Yoshida, H. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05639.x · Cited by 1,086
Martin, M., Rehani, K., Jope, R. S., & Michalek, S. M. (2005) · Nature Immunology · doi:10.1038/ni1221 · Cited by 1,080
Endoplasmic reticulum stress signalling-from basic mechanisms to clinical applications
Almanza, A., Carlesso, A., Chintha, C., Creedican, S., Doultsinos, D., Leuzzi, B., Luís, A., McCarthy, N., Montibeller, L., More, S., et al. (2019) · The FEBS Journal · doi:10.1111/febs.14608 · Cited by 1,034
Juhaszova, M., Zorov, D. B., Kim, S.-H., Pepe, S., Fu, Q., Fishbein, K. W., Ziman, B. D., Wang, S., Ytrehus, K., Antos, C. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19906 · Cited by 1,026
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Embi, N., Rylatt, D. B., & Cohen, P. (1980) · PubMed · Cited by 911
Hypothalamic insulin signaling is required for inhibition of glucose production
Obici, S., Zhang, B. B., Karkanias, G., & Rossetti, L. (2002) · Nature Medicine · doi:10.1038/nm1202-798 · Cited by 904
GSK-3β Regulates Phosphorylation of CRMP-2 and Neuronal Polarity
Yoshimura, T., Kawano, Y., Arimura, N., Kawabata, S., Kikuchi, A., & Kaibuchi, K. (2005) · Cell · doi:10.1016/j.cell.2004.11.012 · Cited by 875
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Woodgett, J. R., & Mills, G. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413597 · Cited by 830
GSK3 inhibitors: development and therapeutic potential
Cohen, P., & Goedert, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1415 · Cited by 790
EMBI, N., RYLATT, D. B., & COHEN, P. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06059.x · Cited by 779
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774
Mao, Y., Ge, X., Frank, C. L., Madison, J. M., Koehler, A. N., Doud, M. K., Tassa, C., Berry, E. M., Soda, T., Singh, K. K., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.044 · Cited by 774
The axonal transport of mitochondria
Hollenbeck, P. J., & Saxton, W. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02745 · Cited by 771
Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3–independent β-catenin degradation
Topol, L., Jiang, X., Choi, H., Garrett-Beal, L., Carolan, P. J., & Yang, Y. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303158 · Cited by 724
p53 status determines the role of autophagy in pancreatic tumour development
Rosenfeldt, M. T., O’Prey, J., Morton, J. P., Nixon, C., MacKay, G., Mrowinska, A., Au, A., Rai, T. S., Zheng, L., Ridgway, R., et al. (2013) · Nature · doi:10.1038/nature12865 · Cited by 713
The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway
Lee, E., Salic, A., Krüger, R., Heinrich, R., & Kirschner, M. W. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000010 · Cited by 708
Insulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production
Könner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., Xu, C., Enriori, P., Hampel, B., Barsh, G. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.004 · Cited by 695
Signal transduction through beta-catenin and specification of cell fate during embryogenesis.
Miller, J. R., & Moon, R. T. (1996) · Genes & Development · doi:10.1101/gad.10.20.2527 · Cited by 656
The oncogenic activation of β-catenin
Polakis, P. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80003-3 · Cited by 653
β-Catenin destruction complex: insights and questions from a structural perspective
Kimelman, D., & Xu, W. (2006) · Oncogene · doi:10.1038/sj.onc.1210055 · Cited by 628 · cited 2×
“Activation of the Wnt signaling pathway does not inhibit the enzymatic activity of GSK3, especially the small amount of GSK3 bound to Axin.272,273 Instead, Axin protein seems to be the rate‐limiting component in regulating the activity of the β‐catenin destruction complex at a very low concentration based on experimen…”
BackgroundErk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin
Ding, Q., Xia, W., Liu, J.-C., Yang, J.-Y., Lee, D.-F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.009 · Cited by 597
Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis
McManus, E. J., Sakamoto, K., Armit, L. J., Ronaldson, L., Shpiro, N., Marquez, R., & Alessi, D. R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600633 · Cited by 594
Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway
Chau, M. D. L., Gao, J., Yang, Q., Wu, Z., & Gromada, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006962107 · Cited by 544
St-Pierre, J., Lin, J., Krauss, S., Tarr, P. T., Yang, R., Newgard, C. B., & Spiegelman, B. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301850200 · Cited by 542
Ring, D. B., Johnson, K. W., Henriksen, E. J., Nuss, J. M., Goff, D., Kinnick, T. R., Ma, S. T., Reeder, J. W., Samuels, I., Slabiak, T., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.3.588 · Cited by 532
Zhou, F.-Q., Zhou, J., Dedhar, S., Wu, Y.-H., & Snider, W. D. (2004) · Neuron · doi:10.1016/j.neuron.2004.05.011 · Cited by 528
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 522
Hoshi, M., Sato, M., Matsumoto, S., Noguchi, A., Yasutake, K., Yoshida, N., & Sato, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1237107100 · Cited by 496
Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation
Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B., et al. (2008) · Science · doi:10.1126/science.1156037 · Cited by 484
Doble, B. W., Patel, S., Wood, G. A., Kockeritz, L. K., & Woodgett, J. R. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.001 · Cited by 448
Role of Glycogen Synthase Kinase-3β in Neuronal Apoptosis Induced by Trophic Withdrawal
Hetman, M., Cavanaugh, J. E., Kimelman, D., & Xia, Z. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02567.2000 · Cited by 440
Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
Luo, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.05.045 · Cited by 429
Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling
Ding, V. W., Chen, R.-H., & McCormick, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005342200 · Cited by 427
Liu, J., Stevens, J., Rote, C. A., Yost, H. J., Hu, Y., Neufeld, K. L., White, R. L., & Matsunami, N. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00241-6 · Cited by 422
Glycogen synthase kinase 3: an emerging therapeutic target
Eldar-Finkelman, H. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02266-3 · Cited by 407
IFN-γ Suppresses IL-10 Production and Synergizes with TLR2 by Regulating GSK3 and CREB/AP-1 Proteins
Hu, X., Paik, P. K., Chen, J., Yarilina, A., Kockeritz, L., Lu, T. T., Woodgett, J. R., & Ivashkiv, L. B. (2006) · Immunity · doi:10.1016/j.immuni.2006.02.014 · Cited by 406
A brain-liver circuit regulates glucose homeostasis
Pocai, A., Obici, S., Schwartz, G. J., & Rossetti, L. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.11.001 · Cited by 392
Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
Haq, S., Choukroun, G., Kang, Z. B., Ranu, H., Matsui, T., Rosenzweig, A., Molkentin, J. D., Alessandrini, A., Woodgett, J., Hajjar, R., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.1.117 · Cited by 392
Tremblay, F., Krebs, M., Dombrowski, L., Brehm, A., Bernroider, E., Roth, E., Nowotny, P., Waldhäusl, W., Marette, A., & Roden, M. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2674 · Cited by 370
GSK3-TIP60-ULK1 Signaling Pathway Links Growth Factor Deprivation to Autophagy
Lin, S.-Y., Li, T. Y., Liu, Q., Zhang, C., Li, X., Chen, Y., Zhang, S.-M., Lian, G., Liu, Q., Ruan, K., et al. (2012) · Science · doi:10.1126/science.1217032 · Cited by 365
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
Beaulieu, J.-M., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2008) · Cell · doi:10.1016/j.cell.2007.11.041 · Cited by 362
Nikoulina, S. E., Ciaraldi, T. P., Mudaliar, S., Mohideen, P., Carter, L., & Henry, R. R. (2000) · Diabetes · doi:10.2337/diabetes.49.2.263 · Cited by 357
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
Eldar-Finkelman, H., & Martinez, A. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00032 · Cited by 354
Control of β-Catenin Stability
Salic, A., Lee, E., Mayer, L., & Kirschner, M. W. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80446-3 · Cited by 335
Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3‐kinase activation
Bijur, G. N., & Jope, R. S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02113.x · Cited by 331
Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
del Ser, T., Steinwachs, K. C., Gertz, H. J., Andrés, M. V., Gómez-Carrillo, B., Medina, M., Vericat, J. A., Redondo, P., Fleet, D., & León, T. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120805 · Cited by 329
Ougolkov, A. V., Fernandez-Zapico, M. E., Savoy, D. N., Urrutia, R. A., & Billadeau, D. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3642 · Cited by 327
Sirtuins Link Inflammation and Metabolism
Vachharajani, V. T., Liu, T., Wang, X., Hoth, J. J., Yoza, B. K., & McCall, C. E. (2016) · Journal of Immunology Research · doi:10.1155/2016/8167273 · Cited by 320
Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action
Eldar-Finkelman, H., & Krebs, E. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9660 · Cited by 319
Mottet, D., Dumont, V., Deccache, Y., Demazy, C., Ninane, N., Raes, M., & Michiels, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300763200 · Cited by 316
S6K1 Regulates GSK3 under Conditions of mTOR-Dependent Feedback Inhibition of Akt
Zhang, H. H., Lipovsky, A. I., Dibble, C. C., Sahin, M., & Manning, B. D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.09.019 · Cited by 308
Gsk3 is a metabolic checkpoint regulator in B cells
Jellusova, J., Cato, M. H., Apgar, J. R., Ramezani-Rad, P., Leung, C. R., Chen, C., Richardson, A. D., Conner, E. M., Benschop, R. J., Woodgett, J. R., et al. (2017) · Nature Immunology · doi:10.1038/ni.3664 · Cited by 303
Kerouz, N. J., Hörsch, D., Pons, S., & Kahn, C. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119872 · Cited by 302
Elgendy, M., Cirò, M., Hosseini, A., Weiszmann, J., Mazzarella, L., Ferrari, E., Cazzoli, R., Curigliano, G., DeCensi, A., Bonanni, B., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.007 · Cited by 299
Glycogen Synthase Kinase 3α-Specific Regulation of Murine Hepatic Glycogen Metabolism
MacAulay, K., Doble, B. W., Patel, S., Hansotia, T., Sinclair, E. M., Drucker, D. J., Nagy, A., & Woodgett, J. R. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.013 · Cited by 299
Jolivalt, C. G., Lee, C. A., Beiswenger, K. K., Smith, J. L., Orlov, M., Torrance, M. A., & Masliah, E. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21787 · Cited by 287
Wg/Wnt Signal Can Be Transmitted through Arrow/LRP5,6 and Axin Independently of Zw3/Gsk3β Activity
Tolwinski, N. S., Wehrli, M., Rives, A., Erdeniz, N., DiNardo, S., & Wieschaus, E. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00063-7 · Cited by 286
Targeting GSK3 and Associated Signaling Pathways Involved in Cancer
Duda, P., Akula, S. M., Abrams, S. L., Steelman, L. S., Martelli, A. M., Cocco, L., Ratti, S., Candido, S., Libra, M., Montalto, G., et al. (2020) · Cells · doi:10.3390/cells9051110 · Cited by 284
Anderson, R. M., Barger, J. L., Edwards, M. G., Braun, K. H., O’Connor, C. E., Prolla, T. A., & Weindruch, R. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2007.00357.x · Cited by 283
A Chaperone-Dependent GSK3β Transitional Intermediate Mediates Activation-Loop Autophosphorylation
Lochhead, P. A., Kinstrie, R., Sibbet, G., Rawjee, T., Morrice, N., & Cleghon, V. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.10.009 · Cited by 283
Hoshi, M., Takashima, A., Noguchi, K., Murayama, M., Sato, M., Kondo, S., Saitoh, Y., Ishiguro, K., Hoshino, T., & Imahori, K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2719 · Cited by 275
Shakoori, A., Ougolkov, A., Yu, Z. W., Zhang, B., Modarressi, M. H., Billadeau, D. D., Mai, M., Takahashi, Y., & Minamoto, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.041 · Cited by 272
Wang, Y., Lam, J. B., Lam, K. S. L., Liu, J., Lam, M. C., Hoo, R. L. C., Wu, D., Cooper, G. J. S., & Xu, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1969 · Cited by 270
HDAC6 Regulates Mitochondrial Transport in Hippocampal Neurons
Chen, S., Owens, G. C., Makarenkova, H., & Edelman, D. B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010848 · Cited by 270
Tissue-Specific Role of Glycogen Synthase Kinase 3β in Glucose Homeostasis and Insulin Action
Patel, S., Doble, B. W., MacAulay, K., Sinclair, E. M., Drucker, D. J., & Woodgett, J. R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00763-08 · Cited by 260
Morisco, C., Zebrowski, D., Condorelli, G., Tsichlis, P., Vatner, S. F., & Sadoshima, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14466 · Cited by 258
Flügel, D., Görlach, A., Michiels, C., & Kietzmann, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00015-07 · Cited by 258
Song, L., De Sarno, P., & Jope, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206047200 · Cited by 256
McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Abrams, S. L., Montalto, G., D'Assoro, A. B., Libra, M., Nicoletti, F., Maestro, R., et al. (2014) · Leukemia · doi:10.1038/leu.2013.184 · Cited by 255
Wnt Signaling Inhibits Adipogenesis through β-Catenin-dependent and -independent Mechanisms
Kennell, J. A., & MacDougald, O. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501080200 · Cited by 253
Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.
Eldar-Finkelman, H., Schreyer, S. A., Shinohara, M. M., LeBoeuf, R. C., & Krebs, E. G. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1662 · Cited by 252
Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder
Schloesser, R. J., Huang, J., Klein, P. S., & Manji, H. K. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301575 · Cited by 249
The role of GSK3 in glucose homeostasis and the development of insulin resistance
Lee, J., & Kim, M.-S. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.033 · Cited by 245
Moule, S. K., Welsh, G. I., Edgell, N. J., Foulstone, E. J., Proud, C. G., & Denton, R. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7713 · Cited by 244
The Key Roles of GSK-3β in Regulating Mitochondrial Activity
Yang, K., Chen, Z., Gao, J., Shi, W., Li, L., Jiang, S., Hu, H., Liu, Z., Xu, D., & Wu, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485580 · Cited by 238
Involvement of Notch signaling in hippocampal synaptic plasticity
Wang, Y., Chan, S. L., Miele, L., Yao, P. J., Mackes, J., Ingram, D. K., Mattson, M. P., & Furukawa, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308126101 · Cited by 235
Nishihara, M., Miura, T., Miki, T., Tanno, M., Yano, T., Naitoh, K., Ohori, K., Hotta, H., Terashima, Y., & Shimamoto, K. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.010 · Cited by 235
Kim, W.-Y., Zhou, F.-Q., Zhou, J., Yokota, Y., Wang, Y.-M., Yoshimura, T., Kaibuchi, K., Woodgett, J. R., Anton, E. S., & Snider, W. D. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.031 · Cited by 235
Multifaceted Roles of GSK‐3 in Cancer and Autophagy‐Related Diseases
Mancinelli, R., Carpino, G., Petrungaro, S., Mammola, C. L., Tomaipitinca, L., Filippini, A., Facchiano, A., Ziparo, E., & Giampietri, C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4629495 · Cited by 235
Cline, G. W., Johnson, K., Regittnig, W., Perret, P., Tozzo, E., Xiao, L., Damico, C., & Shulman, G. I. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2903 · Cited by 228
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease
Maqbool, M., Mobashir, M., & Hoda, N. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.018 · Cited by 227
Inhibition of AMPK Catabolic Action by GSK3
Suzuki, T., Bridges, D., Nakada, D., Skiniotis, G., Morrison, S. J., Lin, J. D., Saltiel, A. R., & Inoki, K. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.03.022 · Cited by 225
SIRT1 Deacetylase in POMC Neurons Is Required for Homeostatic Defenses against Diet-Induced Obesity
Ramadori, G., Fujikawa, T., Fukuda, M., Anderson, J., Morgan, D. A., Mostoslavsky, R., Stuart, R. C., Perello, M., Vianna, C. R., Nillni, E. A., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.010 · Cited by 224
Lochhead, P. A., Coghlan, M., Rice, S. Q. J., & Sutherland, C. (2001) · Diabetes · doi:10.2337/diabetes.50.5.937 · Cited by 219
The GSK-3 Family as Therapeutic Target for Myocardial Diseases
Lal, H., Ahmad, F., Woodgett, J., & Force, T. (2015) · Circulation Research · doi:10.1161/circresaha.116.303613 · Cited by 206
Glycogen synthase kinase-3β is highly activated in nuclei and mitochondria
Bijur, G. N., & Jope, R. S. (2003) · NeuroReport · doi:10.1097/00001756-200312190-00025 · Cited by 203
Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
Shen, W., Taylor, B., Jin, Q., Nguyen-Tran, V., Meeusen, S., Zhang, Y.-Q., Kamireddy, A., Swafford, A., Powers, A. F., Walker, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9372 · Cited by 203
Self-citationNikoulina, S. E., Ciaraldi, T. P., Mudaliar, S., Carter, L., Johnson, K., & Henry, R. R. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2190 · Cited by 198
Glycogen Synthase Kinase 3 Is an Insulin-Regulated C/EBPα Kinase
Ross, S. E., Erickson, R. L., Hemati, N., & MacDougald, O. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8433 · Cited by 197
Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
Pandey, M. K., & DeGrado, T. R. (2016) · Theranostics · doi:10.7150/thno.14334 · Cited by 197
Chen, E. Y., Mazure, N. M., Cooper, J. A., & Giaccia, A. J. (2001) · PubMed · Cited by 194
Horike, N., Sakoda, H., Kushiyama, A., Ono, H., Fujishiro, M., Kamata, H., Nishiyama, K., Uchijima, Y., Kurihara, Y., Kurihara, H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802537200 · Cited by 192
Flügel, D., Görlach, A., & Kietzmann, T. (2012) · Blood · doi:10.1182/blood-2011-08-375014 · Cited by 191
Differential Regulation of STAT Family Members by Glycogen Synthase Kinase-3
Beurel, E., & Jope, R. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802481200 · Cited by 190
Innate Immune Receptors: Key Regulators of Metabolic Disease Progression
Jin, C., Henao-Mejia, J., & Flavell, R. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.011 · Cited by 189
Olson, B. L., Hock, M. B., Ekholm-Reed, S., Wohlschlegel, J. A., Dev, K. K., Kralli, A., & Reed, S. I. (2008) · Genes & Development · doi:10.1101/gad.1624208 · Cited by 185
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
Momcilovic, M., Bailey, S. T., Lee, J. T., Fishbein, M. C., Braas, D., Go, J., Graeber, T. G., Parlati, F., Demo, S., Li, R., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.002 · Cited by 181
GSK‐3 in Neurodegenerative Diseases
Lei, P., Ayton, S., Bush, A. I., & Adlard, P. A. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/189246 · Cited by 177
Cheng, Y., Pardo, M., Armini, R. D. S., Martinez, A., Mouhsine, H., Zagury, J.-F., Jope, R. S., & Beurel, E. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.012 · Cited by 174
Sayas, C. L., Moreno-Flores, M. T., Avila, J., & Wandosell, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37046 · Cited by 172
GSK-3β and Microtubule Assembly in Axons
Zhou, F., & Snider, W. D. (2005) · Science · doi:10.1126/science.1110301 · Cited by 171
GSK-3α is a central regulator of age-related pathologies in mice
Zhou, J., Freeman, T. A., Ahmad, F., Shang, X., Mangano, E., Gao, E., Farber, J., Wang, Y., Ma, X.-L., Woodgett, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64398 · Cited by 169
Marchand, B., Arsenault, D., Raymond-Fleury, A., Boisvert, F.-M., & Boucher, M.-J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616714 · Cited by 168
Wang, Y., Feng, W., Xue, W., Tan, Y., Hein, D. W., Li, X.-K., & Cai, L. (2009) · Diabetes · doi:10.2337/db08-1697 · Cited by 167
Kinase-Inactive Glycogen Synthase Kinase 3β Promotes Wnt Signaling and Mammary Tumorigenesis
Farago, M., Dominguez, I. M., Landesman‐Bollag, E., Xu, X., Rosner, A., Cardiff, R. D., & Seldin, D. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1021 · Cited by 166
Inhibition of GSK3 Promotes Replication and Survival of Pancreatic Beta Cells
Mußmann, R., Geese, M., Harder, F., Kegel, S., Andag, U., Lomow, A., Burk, U., Onichtchouk, D., Dohrmann, C. E., & Austen, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609637200 · Cited by 161
Srinivasan, S., Ohsugi, M., Liu, Z., Fatrai, S., Bernal-Mizrachi, E., & Permutt, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.4.968 · Cited by 161
McCubrey, J. A., Rakus, D., Gizak, A., Steelman, L. S., Abrams, S. L., Lertpiriyapong, K., Fitzgerald, T. L., Yang, L. V., Montalto, G., Cervello, M., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.09.004 · Cited by 161
Glycogen synthase kinase‐3β is a pivotal mediator of cancer invasion and resistance to therapy
Domoto, T., Pyko, I. V., Furuta, T., Miyashita, K., Uehara, M., Shimasaki, T., Nakada, M., & Minamoto, T. (2016) · Cancer Science · doi:10.1111/cas.13028 · Cited by 160
Rochat, A., Fernandez, A., Vandromme, M., Molès, J., Bouschet, T., Carnac, G., & Lamb, N. J. C. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-11-0816 · Cited by 159
Waypa, G. B., Marks, J. D., Guzy, R. D., Mungai, P. T., Schriewer, J. M., Đokić, D., Ball, M. K., & Schumacker, P. T. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1294oc · Cited by 155
Muntané, G., Dalfó, E., Martínez, A., & Ferrer, I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.030 · Cited by 153
ER Stress Inhibits mTORC2 and Akt Signaling Through GSK-3β–Mediated Phosphorylation of Rictor
Chen, C.-H., Shaiken, T. E., Peterson, T. R., Aimbetov, R., Bissenbaev, A. K., Lee, S.-W., Wu, J., Lin, H., & Sarbassov, D. D. (2011) · Science Signaling · doi:10.1126/scisignal.2001731 · Cited by 152
Kanazawa, A., Tsukada, S., Kamiyama, M., Yanagimoto, T., Nakajima, M., & Maeda, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.007 · Cited by 148
Leptin Impairs Insulin Signaling in Rat Adipocytes
Pérez, C., Fernández‐Galaz, C., Fernández‐Agulló, T., Arribas, C., Andrés, A., Ros, M., & Carrascosa, J. M. (2004) · Diabetes · doi:10.2337/diabetes.53.2.347 · Cited by 148
mTORC1 Promotes Metabolic Reprogramming by the Suppression of GSK3-dependent Foxk1 Phosphorylation
He, L., Gomes, A. P., Wang, X., Yoon, S. O., Lee, G., Nagiec, M. J., Cho, S., Chavez, A., Islam, T., Yu, Y., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.04.024 · Cited by 145
Targeting Gsk-3: A Promising Approach For Cancer Therapy?
Ougolkov, A. V., & Billadeau, D. D. (2006) · Future Oncology · doi:10.2217/14796694.2.1.91 · Cited by 143
Lin, C.-J., Chen, T.-H., Yang, L.-Y., & Shih, C.-M. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.123 · Cited by 142
Loberg, R. D., Vesely, E. D., & Brosius, F. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206405200 · Cited by 141
Markuns, J. F., Wojtaszewski, J. F. P., & Goodyear, L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24896 · Cited by 140
Kim, S., Joe, Y., Kim, H. J., Kim, Y., Jeong, S. O., Pae, H., Ryter, S. W., Surh, Y., & Chung, H. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401399 · Cited by 139
Yao, H.-B., Shaw, P., Wong, C.-C., & Wan, D. C. (2002) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(02)00014-5 · Cited by 138
Distinct roles of GSK-3α and GSK-3β phosphorylation in the heart under pressure overload
Matsuda, T., Zhai, P., Maejima, Y., Hong, C., Gao, S., Tian, B., Goto, K., Takagi, H., Tamamori‐Adachi, M., Kitajima, S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808315106 · Cited by 138
Hypoxia activates Akt and induces phosphorylation of GSK-3 in PC12 cells
Beitner‐Johnson, D., Rust, R. T., Hsieh, T. ‐., & Millhorn, D. E. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00128-5 · Cited by 134
Regulation of Glycogen Synthesis by Amino Acids in Cultured Human Muscle Cells
Armstrong, J. L., Bonavaud, S. M., Toole, B. J., & Yeaman, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004812200 · Cited by 133
Stressed and Inflamed, Can GSK3 Be Blamed?
Jope, R. S., Cheng, Y., Lowell, J. A., Worthen, R. J., Sitbon, Y. H., & Beurel, E. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.10.009 · Cited by 132
mTOR regulates brain morphogenesis by mediating GSK3 signaling
Ka, M., Condorelli, G., Woodgett, J. R., & Kim, W.-Y. (2014) · Development · doi:10.1242/dev.108282 · Cited by 130
Serotonin stimulates mitochondrial transport in hippocampal neurons
Chen, S., Owens, G. C., Crossin, K. L., & Edelman, D. B. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.08.004 · Cited by 129
Brady, M., Bourbonais, F., & Saltiel, A. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14063 · Cited by 124
Cadmium Toxicity toward Autophagy through ROS-Activated GSK-3β in Mesangial Cells
Wang, S.-H., Shih, Y., Kuo, T.-C., Ko, W., & Shih, C.-M. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfn266 · Cited by 124
Recent advances in understanding the cellular roles of GSK-3
Cormier, K. W., & Woodgett, J. R. (2017) · F1000Research · doi:10.12688/f1000research.10557.1 · Cited by 124
Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
Saraswati, A. P., Hussaini, S. M. A., Krishna, N. H., Babu, B. N., & Kamal, Ä. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.103 · Cited by 124
Inhibition of Glycogen Synthase Kinase 3β During Heart Failure Is Protective
Hirotani, S., Zhai, P., Tomita, H., Galeotti, J., Marquez, J. P., Gao, S., Hong, C., Yatani, A., Ávila, J., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/circresaha.107.160614 · Cited by 123
van der Velden, J. L. J., LANGEN, R. C. J., KELDERS, M. C. J. M., Wouters, E. F. �., Janssen-Heininger, Y. M. W., & Schols, A. M. W. J. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00068.2005 · Cited by 122
Azoulay‐Alfaguter, I., Elya, R., Avrahami, L., Katz, A., & Eldar-Finkelman, H. (2014) · Oncogene · doi:10.1038/onc.2014.390 · Cited by 121
Pluquet, O., Qu, L., Baltzis, D., & Koromilas, A. E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9392-9405.2005 · Cited by 121
Dokken, B. B., Sloniger, J. A., & Henriksen, E. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00547.2004 · Cited by 120
Leptin inhibits glycogen synthase kinase-3β to prevent tau phosphorylation in neuronal cells
Greco, S. J., Sarkar, S., Casadesús, G., Zhu, X., Smith, M. A., Ashford, J. W., Johnston, J. M., & Tezapsidis, N. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.066 · Cited by 119
Boucher, M., Selander, L., Carlsson, L., & Edlund, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511597200 · Cited by 118
Woulfe, K. C., Gao, E., Lal, H., Harris, D., Fan, Q. N., Vagnozzi, R. J., DeCaul, M., Shang, X., Patel, S., Woodgett, J. R., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.211482 · Cited by 118
Tanabe, K., Liu, Z., Patel, S., Doble, B. W., Li, C., CRAS-MÉNEUR, C. M. H., Martinez, S. C., Welling, C. M., White, M. F., Bernal‐Mizrachi, E., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060037 · Cited by 118
Sirt1 Promotes Axonogenesis by Deacetylation of Akt and Inactivation of GSK3
Li, X., Chen, C., Tu, Y., Sun, H., Zhao, M., Cheng, S., Qu, Y., & Zhang, S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8437-3 · Cited by 117
Petit-Paitel, A., Brau, F., Cazareth, J., & Chabry, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005491 · Cited by 117
Kaidanovich‐Beilin, O., & Eldar-Finkelman, H. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090266 · Cited by 113
Pearce, N. J., Arch, J. R. S., Clapham, J. C., Coghlan, M. P., Corcoran, S. L., Lister, C. A., Llano, A., Moore, G. B. T., Murphy, G. J., Smith, S. A., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2004.05.008 · Cited by 111
Valerio, A., Ghisi, V., Dossena, M., Tonello, C., Giordano, A., Frontini, A., Ferrario, M., Pizzi, M., Spano, P., Carruba, M. O., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508691200 · Cited by 110
Banerji, V., Frumm, S. M., Ross, K. N., Li, L. S., Schinzel, A. C., Hahn, C. K., Kakoza, R. M., Chow, K. T., Ross, L., Alexe, G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci46465 · Cited by 105
Liu, Z., Tanabe, K., Bernal‐Mizrachi, E., & Permutt, M. A. (2008) · Diabetologia · doi:10.1007/s00125-007-0914-7 · Cited by 104
Liu, Y., Tanabe, K., Baronnier, D., Patel, S., Woodgett, J. R., CRAS-MÉNEUR, C. M. H., & Permutt, M. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1882-x · Cited by 104
Dan, L., Klimenkova, O., Klimiankou, M., Klusmann, J., van den Heuvel‐Eibrink, M. M., Reinhardt, D., Welte, K., & Skokowa, J. (2011) · Haematologica · doi:10.3324/haematol.2011.055236 · Cited by 104
Wagner, F. F., Benajiba, L., Campbell, A. J., Weïwer, M., Sacher, J. R., Gale, J. P., Ross, L. S., Puissant, A., Alexe, G., Conway, A. S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam8460 · Cited by 104
Regulation of GSK3 isoforms by phosphatases PP1 and PP2A
Hernández, F., Langa, E., Cuadros, R., Ávila, J., & Villanueva, N. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0544-0 · Cited by 103
A partnership with the proteasome; the destructive nature of GSK3
Robertson, H., Hayes, J. D., & Sutherland, C. D. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.10.016 · Cited by 102
Ramírez‐Valle, F., Badura, M. L., Braunstein, S. E., Narasimhan, M., & Schneider, R. J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00322-09 · Cited by 98
Park, D. W., Jiang, S., Liu, Y., Siegal, G. P., Inoki, K., Abraham, E. H., & Zmijewski, J. W. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00165.2014 · Cited by 94
Enhanced glycogenesis is involved in cellular senescence via GSK3/GS modulation
Seo, Y., Jung, H., Shin, H., Kim, Y., Yim, H., Chung, H., Lim, I. K., & Yoon, G. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00436.x · Cited by 90
Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy
Verhees, K. J. P., Schols, A. M. W. J., KELDERS, M. C. J. M., den Kamp, C. M. O., van der Velden, J. L. J., & LANGEN, R. C. J. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00520.2010 · Cited by 90
GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells
Sun, A., Li, C., Chen, R., Huang, Y., Chen, Q., Cui, X., Liu, H., Thrasher, J. B., & Li, B. (2015) · The Prostate · doi:10.1002/pros.23106 · Cited by 89
Sirt1 inhibits the transcription factor CREB to regulate pituitary growth hormone synthesis
Garcia, J. L. M., Al–Massadi, O., Seoane, L. M., Álvarez, C. V., Shan, B., Stalla, J., Páez-Pereda, M., Casanueva, F. F., Stalla, G. K., & Theodoropoulou, M. (2013) · The FASEB Journal · doi:10.1096/fj.12-220129 · Cited by 89
Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia
Cassavaugh, J. M., Hale, S. A., Wellman, T. L., Howe, A. K., Wong, C., & Lounsbury, K. M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23321 · Cited by 88
Koga, T., Suico, M. A., Shimasaki, S., Watanabe, E., Kai, Y., Koyama, K., Omachi, K., Morino‐Koga, S., Sato, T., Shuto, T., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.664169 · Cited by 88
Leptin promotes K ATP channel trafficking by AMPK signaling in pancreatic β-cells
Park, S.-H., Ryu, S.-Y., Yu, W., Han, Y. E., Ji, Y.-S., Oh, K., Sohn, J., Lim, A., Jeon, J.-P., Lee, H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216351110 · Cited by 84
Zhao, J., Wang, H., Huang, Y., Zhang, H., Wang, S., Gaskin, F., Yang, N., & Fu, S. M. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38993 · Cited by 82
Liu, L., Li, C., Lu, Y., Zong, X., Luo, C., Sun, J., & Guo, L. (2015) · Scientific Reports · doi:10.1038/srep14474 · Cited by 82
The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
Augello, G., Emma, M. R., Cusimano, A., Azzolina, A., Montalto, G., McCubrey, J. A., & Cervello, M. (2020) · Cells · doi:10.3390/cells9061427 · Cited by 82
Song, W., Song, E. C., Jung, M., Choi, S., Baik, H.-H., Jin, B. K., Kim, J. H., & Chung, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.594952 · Cited by 81
Gray, J. E., Infante, J. R., Brail, L. H., Simon, G. R., Cooksey, J. F., Jones, S. F., Farrington, D. L., Yeo, A. S. L., Jackson, K. A., Chow, K. H., et al. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0278-7 · Cited by 81
Giménez-Cassina, A., Lim, F., Cerrato, T., Palomo, G. M., & Díaz‐Nido, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808698200 · Cited by 80
GSK3β Regulates Brain Energy Metabolism
Martin, S. A., Souder, D. C., Miller, K. N., Clark, J. P., Sagar, M. A. K., Eliceiri, K. W., Puglielli, L., Beasley, T. M., & Anderson, R. M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.045 · Cited by 80
Cited by
Wu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88
Metadata
- Authors
- Wang, L., Li, J., & Di, L.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2021-11-03
- Volume
- 42
- Issue
- 2
- Pages
- 946-982
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W3211091011
- Cited by
- 261
- References
- 280
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.